A1 Refereed original research article in a scientific journal
PSEN1 Mutant iPSC-Derived Model Reveals Severe Astrocyte Pathology in Alzheimer's Disease
Authors: Oksanen M, Petersen AJ, Naumenko N, Puttonen K, Lehtonen S, Olive MG, Shakirzyanova A, Leskela S, Sarajarvi T, Viitanen M, Rinne JO, Hiltunen M, Haapasalo A, Giniatullin R, Tavi P, Zhang SC, Kanninen KM, Hamalainen RH, Koistinaho J, Koistinaho J
Publisher: CELL PRESS
Publication year: 2017
Journal: Stem Cell Reports
Journal name in source: STEM CELL REPORTS
Journal acronym: STEM CELL REP
Volume: 9
Issue: 6
First page : 1885
Last page: 1897
Number of pages: 13
ISSN: 2213-6711
DOI: https://doi.org/10.1016/j.stemcr.2017.10.016
Self-archived copy’s web address: https://research.utu.fi/converis/portal/detail/Publication/28704437
Alzheimer's disease (AD) is a common neurodegenerative disorder and the leading cause of cognitive impairment. Due to insufficient understanding of the disease mechanisms, there are no efficient therapies for AD. Most studies have focused on neuronal cells, but astrocytes have also been suggested to contribute to AD pathology. We describe here the generation of functional astrocytes from induced pluripotent stem cells (iPSCs) derived from AD patients with PSEN1 Delta E9 mutation, as well as healthy and gene-corrected isogenic controls. AD astrocytes manifest hallmarks of disease pathology, including increased beta-amyloid production, altered cytokine release, and dysregulated Ca2+ homeostasis. Furthermore, due to altered metabolism, AD astrocytes show increased oxidative stress and reduced lactate secretion, as well as compromised neuronal supportive function, as evidenced by altering Ca2+ transients in healthy neurons. Our results reveal an important role for astrocytes in AD pathology and highlight the strength of iPSC-derived models for brain diseases.
Downloadable publication This is an electronic reprint of the original article. |  |
